Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia

Neuroscience Letters

Volumn 248, Issue 1, 1998, Pages 5-8

  Shadid, Majidah ^a   Buonocore, Giuseppe ^b   Groenendaal, Floris ^c   Moison, Ralph ^a   Ferrali, Marco ^b   Berger, Howard M ^a   Van Bel, Frank ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Allopurinol; Brain; Deferoxamine; Hypoxia ischemia; Newborn; Non protein bound iron

Indexed keywords

ALLOPURINOL; DEFEROXAMINE; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN LEVEL; DRUG EFFECT; IRON BLOOD LEVEL; IRON CHELATION; LAMB; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ALLOPURINOL; ANIMALS; ANIMALS, NEWBORN; BRAIN ISCHEMIA; CEREBRAL CORTEX; DEFEROXAMINE; HYPOXIA, BRAIN; IRON; IRON CHELATING AGENTS; NERVE TISSUE PROTEINS; PROTEIN BINDING; SHEEP;

EID: 0032557422     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00303-6     Document Type: Article

References (26)

1. Bralet J., Schreiber L., Bouvier C. Effect of acidosis and anoxia on iron delocalization from brain homogenates. Biochem. Pharmacol. 43:1992;979-983.
2. deLemos R.A., Roberts R.J., Coalson J.J., deLemos J.A., Null D.M., Gerstmann D.R. Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease. AJDC. 144:1990;915-919.
3. Dorrepaal C.A., Berger H.M., Benders M.J.N.L., Van Zoeren-Grobben D., Van De Bor M., Van Bel F. Nonprotein bound iron in postasphyxial reperfusion injury of the newborn. Pediatrics. 98:1996;883-889.
4. Dorrepaal C.A., Shadid M., Steendijk P., Van Der Velde E.T., Van De Bor M., Baan J., Van Bel F. Effect of post hypoxic-ischemic inhibition of nitric oxide synthesis on cerebral blood flow, metabolism and electrocortical brain activity in newborn lambs. Biol. Neonatol. 72:1997;216-226.
5. Ferrali M., Ciccoli L., Comporti M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem. Pharmacol. 38:1989;1819-1825.
6. Fordor J.R., McClanahan T.B., Gallagher K.P., Hedlund B.E., Hallaway P.E., Shlafer M. Hemodynamic effects of intraarterial administration of deferoxamine or deferoxamine-pentafraction conjugate to conscious dogs. J. Cardiovasc. Pharmacol. 16:1990;742-749.
7. Gutteridge J.M.C. Iron and oxygen radicals in brain. Ann. Neurol. 32:1992;S16-S21.
8. Gutteridge, J.M.C. and Halliwell, B., Bleomycin assay for catalytic iron salts in body fluids. In R.A. Greenwald (Ed.), CRC Handbook of Methods for Oxygen Radical Research, CRC press, Boca Raton, FL, 1985, pp. 391-394.
9. Gutteridge J.M.C., Halliwell B. Radical-promoting loosely bound iron in biological fluids and the bleomycin assay. Life Chem. Rep. 4:1987;113-142.
10. Hallaway P.E., Eaton J.W., Panter S.S., Hedlund B.E. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc. Nat. Acad. Sci. USA. 86:1989;10108-10112.
11. Halliwell B. Reactive oxygen species and the cerebral nervous system. J. Neurol. Chem. 59:1992;1609-1623.
12. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurements and significance. Am. J. Clin. Nutr. 57:1993;715S-725S.
13. Hedlund B.E., Hallaway P.E. High dose systemic iron chelation attenuates reperfusion injury. Biochem. Soc. Trans. 21:1993;340-343.
14. Hurn P.D., Koehler R.C., Blizzard K.K., Traystman J. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke. 26:1995;688-695.
15. Ko K.M., Godin D.V. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem. Pharmacol. 40:1990;803-809.
16. May, N.D.S., The Anatomy of Sheep: a Dissection Manual. University of Queensland press, 1970, pp. 133-266.
17. McCord J.M. Oxygen derived free radicals in post ischemic tissue injury. N. Engl. J. Med. 312:1985;159-163.
18. Morita K., Ihnken K., Buckberg G.D., Sherman M.P., Young H.H. Studies of hypoxemic/reoxygenation injury: without aortic clamping. J. Thorac. Cardiovasc. Surg. 110:1995;1190-1199.
19. Palmer C., Vannucci R.C., Towfighi J. Reduction of perinatal hypoxic ischemic brain damage with allopurinol. Pediatr. Res. 27:1990;332-336.
20. Palmer C., Roberts R.L., Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 25:1994;1039-1045.
21. Saugstad O.D., Aasen A.O. Plasma hypoxanthine concentrations in pigs: a prognostic aid in hypoxia. Eur. Surg. Res. 12:1986;123-129.
22. Shadid, M., Moison, R.M.W., Hiltermann, L., Berger, H.M. and Van Bel, F., Anti oxidative combination therapy and post hypoxic-ischemic reperfusion injury of the newborn brain, Pediatr. Res., in press.
23. Van Bel F., Shadid M., Moison R.M.W., Dorrepaal C.A., Fontijn J., Monteiro L., Van De Bor M., Berger H.M. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics and electrical brain activity. Pediatrics. 101:1998;185-195.
24. Vanucci R.C. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr. Res. 27:1990;317-326.
25. Volpe, J.J., (Ed.), Neurology of the Newborn, 3rd edn., W.B. Saunders, Philadelphia, 1995, pp. 211-369.
26. Voogd A., Sluiter W., Van Eijk H.G., Koster J.F. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J. Clin. Invest. 90:1992;2050-2055.